Alex Loftis, Ph.D., is a Principal at Vida Ventures.
Prior to his current role, Alex was a life sciences consultant at L.E.K. Consulting in Boston, where he worked closely with biopharma clients on strategic initiatives, including due diligence, corporate strategy, and market assessments. Before his consulting career, Alex was a Fellow at Vida Ventures in the firm’s Boston office.
Alex earned his Ph.D. from the Massachusetts Institute of Technology (MIT), where his research focused on antigen-specific tolerance induction, peptide drug discovery, and protein engineering. As a Biotechnology Training Program Fellow, Alex developed expertise in the intersection of immunology and drug development, working on projects aimed at advancing therapeutic strategies for autoimmune diseases and other immune-mediated conditions.
He graduated summa cum laude from Washington University in St. Louis with an A.B. in Chemistry, where he developed a strong foundation in the principles of chemical biology and molecular science.